Buda Juice (BUDA) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 30, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BUDA SEC filings page.
Buda Juice, Inc. (BUDA) reported $12.6M in revenue for fiscal year 2025, up 11.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sales expanded, but higher operating costs and weaker cash conversion kept earnings nearly flat while the balance sheet became more leveraged.
The gap between accounting profit and cash generation widened: net income slipped1.1% , yet operating cash flow fell20.7% , indicating earnings were less fully collected in cash. The change was not caused by heavier reinvestment: capital expenditures fell64.0% , while free cash flow still fell11.7% .
Revenue growth did not translate into operating expansion: revenue rose
The balance sheet remained liquid on a current basis: the current ratio improved from 4.7x to 5.5x. Liabilities rose
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Buda Juice, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Buda Juice, Inc. has an operating margin of 27.4%, meaning the company retains $27 of operating profit per $100 of revenue. This strong profitability earns a score of 93/100, reflecting efficient cost management and pricing power. This is down from 30.3% the prior year.
Buda Juice, Inc.'s revenue grew 11.8% year-over-year to $12.6M, a solid pace of expansion. This earns a growth score of 68/100.
Buda Juice, Inc. carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 92/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 5.50, Buda Juice, Inc. holds $5.50 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 93/100.
Buda Juice, Inc. converts 23.0% of revenue into free cash flow ($2.9M). This strong cash generation earns a score of 91/100.
Buda Juice, Inc. earns a strong 94.5% return on equity (ROE), meaning it generates $95 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 95/100. This is down from 113.2% the prior year.
Buda Juice, Inc. scores 47.72, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $86.1M against total liabilities of $1.2M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Buda Juice, Inc. passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Buda Juice, Inc. generates $0.89 in operating cash flow ($3.1M OCF vs $3.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Buda Juice, Inc. generated $4.5M in revenue in Q2 2026. This represents an increase of 26.4% from the same quarter a year earlier. Against the prior quarter it is up 28.5%.
Buda Juice, Inc.'s EBITDA was $506K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 58.3% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.
Buda Juice, Inc. reported $470K in net income in Q2 2026. This represents a decrease of 59.8% from the same quarter a year earlier. Against the prior quarter it is up 21.1%.
Cash & Balance Sheet
Buda Juice, Inc. held $18.8M in cash against $755K in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Buda Juice, Inc.'s gross margin was 36.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 10.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.9 percentage points.
Buda Juice, Inc.'s operating margin was 9.8% in Q2 2026, reflecting core business profitability. This is down 22.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.1 percentage points.
Buda Juice, Inc.'s net profit margin was 10.4% in Q2 2026, showing the share of revenue converted to profit. This is down 22.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.6 percentage points.
Buda Juice, Inc.'s quarterly ROE was 2.2% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 32.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
Capital Allocation
None of these metrics is reported for Q2 2026.
BUDA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|
| Revenue | $4.5M+26.4% | $3.5M+17.7% | N/A | $3.6M | $3.0M | N/A |
| Cost of Revenue | $2.9M+50.4% | $2.1M+29.2% | N/A | $1.9M | $1.6M | N/A |
| Gross Profit | $1.7M-1.0% | $1.4M+3.6% | N/A | $1.7M | $1.3M | N/A |
| SG&A Expenses | $1.1M+179.1% | $663K+62.9% | N/A | $378K | $407K | N/A |
| Operating Income | $444K-61.2% | $593K-26.2% | N/A | $1.1M | $803K | N/A |
| EBITDA | $506K-58.3% | $650K-27.0% | N/A | $1.2M | $890K | N/A |
| Income Tax | $129K+1333.3% | $359K+3888.9% | N/A | $9K | $9K | N/A |
| Net Income | $470K-59.8% | $388K-51.9% | N/A | $1.2M | $807K | N/A |
| EPS (Basic) | $0.04 | $0.03 | N/A | N/A | N/A | N/A |
| EPS (Diluted) | $0.04 | $0.03 | N/A | N/A | N/A | N/A |
| Diluted Shares (Avg) | 13M | 12,351 | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.
BUDA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|
| Total Assets | $23.8M | $22.9M | $5.0M+33.2% | N/A | N/A | $3.7M |
| Current Assets | $21.6M | $21.0M | $3.2M+19.4% | N/A | N/A | $2.7M |
| Cash & Equivalents | $18.8M+1005.7% | $19.8M+1531.9% | $1.8M-2.5% | $1.7M | $1.2M | $1.9M |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0 | $0 | $0 |
| Inventory | $613K | $445K | $348K-7.0% | N/A | N/A | $374K |
| Accounts Receivable | N/A | $494K | $386K-2.3% | N/A | N/A | $395K |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0 | $0 | $0 |
| Total Liabilities | $2.2M | $1.8M | $1.2M+114.3% | N/A | N/A | $575K |
| Current Liabilities | $1.4M | $1.0M | $585K+1.7% | N/A | N/A | $575K |
| Non-Current Liabilities | $755K | $792K | $647Kn/m | N/A | N/A | $0 |
| Long-Term Debt | $755K | $792K | $647K | N/A | N/A | N/A |
| Total Equity | $21.6M+539.1% | $21.0M+732.8% | $3.7M+18.4% | $3.4M | $2.5M | $3.2M |
| Retained Earnings | $2.0M | $1.6M | $1.2Mn/m | N/A | N/A | -$2.3M |
Not reported in any period shown, so not listed: Goodwill.
BUDA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -$365K-139.3% | $1.3M+44.4% | N/A | $929K | $904K | N/A |
| Depreciation & Amortization | $62K-11.4% | $57K-34.5% | N/A | $70K | $87K | N/A |
| Stock-Based Compensation | $213K | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | $218K+56.8% | N/A | N/A | $139K | N/A |
| Free Cash Flow | N/A | $1.1M+42.1% | N/A | N/A | $765K | N/A |
| Investing Cash Flow | -$570Kn/m | -$218Kn/m | N/A | -$131K | -$139K | N/A |
| Financing Cash Flow | -$74Kn/m | $16.9Mn/m | N/A | -$310K | -$1.4M | N/A |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
BUDA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|
| Gross Margin | 36.6%-10.1pp | 39.5%-5.4pp | N/A | 46.7% | 44.9% | N/A |
| Operating Margin | 9.8%-22.2pp | 16.9%-10.1pp | N/A | 32.1% | 27.0% | N/A |
| Net Margin | 10.4%-22.4pp | 11.1%-16.0pp | N/A | 32.8% | 27.1% | N/A |
| Return on Equity | 2.2%-32.4pp | 1.8%-30.1pp | N/A | 34.6% | 32.0% | N/A |
| Return on Assets | 2.0% | 1.7% | N/A | N/A | N/A | N/A |
| Current Ratio | 15.21 | 20.16 | 5.50+0.8x | N/A | N/A | 4.69 |
| Debt-to-Equity | 0.03 | 0.04 | 0.17 | N/A | N/A | N/A |
| Liabilities-to-Equity | 0.10 | 0.09 | 0.33+0.1x | N/A | N/A | 0.18 |
| Asset Turnover | 0.19 | 0.15 | N/A | N/A | N/A | N/A |
| FCF Margin | N/A | 31.0%+5.3pp | N/A | N/A | 25.7% | N/A |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Buda Juice, Inc. BUDA | FY2025 | $12.6M | $3.5M | 28.0% | $86.1M | 89/100 |
| Zevia PBC ZVIA | FY2025 | $161.3M | -$9.9M | -6.2% | $85.8M | 64/100 |
| Barfresh Food Group Inc. BRFH | FY2025 | $14.2M | -$2.7M | -19.0% | $9.0M | 39/100 |
| Reed's, Inc. REED | FY2025 | $34.1M | -$15.8M | -46.5% | $8.8M | 26/100 |
| Bonk, Inc. BNKK | FY2025 | $2.1M | -$68.2M | N/A | $8.6M | 37/100 |
| HF Foods Group Inc. HFFG | FY2025 | $1.2B | -$38.8M | -3.2% | $80.6M | 33/100 |
Where Buda Juice, Inc. Ranks
Frequently Asked Questions
Buda Juice, Inc. (BUDA) reported $12.6M in total revenue for fiscal year 2025. This represents a 11.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Buda Juice, Inc. (BUDA) revenue grew by 11.8% year-over-year, from $11.3M to $12.6M in fiscal year 2025.
Yes, Buda Juice, Inc. (BUDA) reported a net income of $3.5M in fiscal year 2025, with a net profit margin of 28.0%.
Buda Juice, Inc. (BUDA) had EBITDA of $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Buda Juice, Inc. (BUDA) had $1.8M in cash and equivalents against $647K in long-term debt.
Buda Juice, Inc. (BUDA) had a gross margin of 44.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Buda Juice, Inc. (BUDA) had an operating margin of 27.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Buda Juice, Inc. (BUDA) had a net profit margin of 28.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Buda Juice, Inc. (BUDA) has a return on equity of 94.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Buda Juice, Inc. (BUDA) generated $2.9M in free cash flow during fiscal year 2025. This represents a -11.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Buda Juice, Inc. (BUDA) generated $3.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Buda Juice, Inc. (BUDA) had $5.0M in total assets as of fiscal year 2025, including both current and long-term assets.
Buda Juice, Inc. (BUDA) invested $246K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Buda Juice, Inc. (BUDA) had a current ratio of 5.50 as of fiscal year 2025, which is generally considered healthy.
Buda Juice, Inc. (BUDA) had a debt-to-equity ratio of 0.17 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Buda Juice, Inc. (BUDA) had a liabilities-to-equity ratio of 0.33 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Buda Juice, Inc. (BUDA) had a return on assets of 71.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Buda Juice, Inc. (BUDA) trades at 24.4x earnings, its market capitalization divided by $3.5M net income, FY2025. The market capitalization is $86.1M as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Buda Juice, Inc. (BUDA) trades at 6.8x sales, its market capitalization divided by $12.6M revenue, FY2025. The market capitalization is $86.1M as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Buda Juice, Inc. (BUDA) has an Altman Z-Score of 47.72, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Buda Juice, Inc. (BUDA) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Buda Juice, Inc. (BUDA) has an earnings quality ratio of 0.89x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Buda Juice, Inc. (BUDA) scores 89 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.